Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De)

NCT02620332 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: MultiPepT1De injection
OTHER: Placebo

Sponsor

King's College London

Collaborators

[object Object]